Acquired Reactive Perforating Collagenosis following Cabozantinib – a case report

Key Points

• To describe a case of acquired reactive perforating collagenosis that developed after cabozantinib treatment.
• Case report detailing patient treatment history and outcomes
• Analysis of dermatological symptoms post-treatment
• Documented occurrence of reactive perforating collagenosis in the patient
• Noted improvement in skin condition after cessation of cabozantinib